Top

Published in:

01-09-2009 | Bone and Soft Tissue Sarcomas

Complete Soft Tissue Sarcoma Resection is a Viable Treatment Option for Select Elderly Patients

Authors: G. Lahat, MD, A. R. Dhuka, BSc, S. Lahat, MD, A. J. Lazar, MD, PhD, V. O. Lewis, MD, P. P. Lin, MD, B. Feig, MD, J. N. Cormier, MD, K. K. Hunt, MD, P. W. T. Pisters, MD, R. E. Pollock, MD, PhD, D. Lev, MD

Published in: Annals of Surgical Oncology | Issue 9/2009

Abstract

Background

Decreased performance status, comorbidities, and disease natural history may erode enthusiasm for soft tissue sarcoma (STS) resection in elderly patients. Consequently, we evaluated the outcome of elderly patients amenable to complete surgical resection treated at a single institution.

Methods

Prospectively accrued data were used to identify patients with primary STS age ≥65 years (n = 325) who underwent complete macroscopic resection at our institution (1996–2007). Univariable and multivariable analyses were performed to identify prognostic factors.

Results

Median age at presentation was 72 years; 179 patients (55.1%) had associated comorbidities with an ASA score of ≥3. Extremity was the most common site (57.1%; n = 186), undifferentiated pleomorphic sarcoma the most common histology (60.4%; n = 197); 232 (71.2%) were high grade, 222 (68.3%) were >5 cm. Thirty-day postoperative mortality was 0.9% (n = 3); overall complication rate was 30.7% (n = 100), and mean postoperative hospital stay was 9 days (range, 1–84). Estimated median survival was 96 months, 5-year disease-specific survival (DSS) was 63%. Multivariable analysis identified age ≥75 year (HR = 2.03), tumor size: 5–15 vs <5 cm (HR = 3.54), or >15 vs <5 cm (HR = 10.33), and high-grade (HR = 5.53) as significant independent adverse prognostic factors. Compared with patients aged 65–74 years, older patients had more high grade tumors (P = .04), received chemotherapy less often (P < .0001), developed different patterns of recurrence (P < .05), and exhibited a shorter median survival (70 months; P = .05).

Conclusions

Properly selected elderly patients can safely undergo extensive STS resections. Until more effective therapies become available, surgery in the elderly is indicated and remains the best means for STS control.

Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–30.PubMedCrossRef

Lahat G, Lazar AJ, Lev D. Sarcoma epidemiology and etiology: potential environmental and genetic factors. Surg Clin North Am. 2008;88:451–81.PubMedCrossRef

Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med. 2005;353:701–11.PubMedCrossRef

Eilber FC, Rosen G, Nelson SD, Selch M, Dorey F, Eckardt J, et al. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg. 2003;237:218–26.PubMedCrossRef

Gronchi A, Lo Vullo S, Fiore M, Mussi C, Stacchiotti S, Collini P, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24–30.PubMedCrossRef

Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14:859–68.PubMed

Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197–203.PubMed

Lahat G, Tuvin D, Wei C, Anaya DA, Bekele BN, Lazar AJ, et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg. 2008;15:2739–48.CrossRef

Muss HB. Cancer in the elderly: a societal perspective from the United States. Clin Oncol (R Coll Radiol). 2009;21:92–8.

10.

Surveillance Epidemiology and End Results (SEER) program. http://seer.cancer.gov/statfacts/html/all. Accessed 15 Feb 2009.

11.

Boden RA, Clark MA, Neuhaus SJ, A’hern JR, Thomas JM, Hayes AJ. Surgical management of soft tissue sarcoma in patients over 80 years. Eur J Surg Oncol. 2006;32:1154–8.PubMedCrossRef

12.

Staehler M, Haseke N, Stadler T, Bader M, Karl A, Becker A, et al. Renal surgery in the elderly: morbidity in patients aged >75 years in a contemporary series. BJU Int. 2008;102:684–7.PubMedCrossRef

13.

Tan KY, Kawamura Y, Mizokami K, Sasaki J, Tsujinaka S, Maeda T, et al. Colorectal surgery in octogenarian patients-outcomes and predictors of morbidity. Int J Colorectal Dis. 2009;24:185–9.PubMedCrossRef

14.

Brozzetti S, Mazzoni G, Miccini M, Puma F, De Angelis M, Cassini D, et al. Surgical treatment of pancreatic head carcinoma in elderly patients. Arch Surg. 2006;141:137–42.PubMedCrossRef

15.

Osaka S, Sugita H, Osaka E, Yoshida Y, Ryu J. Surgical management of malignant soft tissue tumours in patients aged 65 years or older. J Orthop Surg (Hong Kong). 2003;11:28–33.

16.

Buchner M, Bernd L, Zahlten-Hinguranage A, Sabo D. Primary malignant tumours of bone and soft tissue in the elderly. Eur J Surg Oncol. 2004;30:877–83.PubMedCrossRef

17.

Behranwala KA, A’Hern R, Omar AM, Thomas J. Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol. 2004;11:714–9.PubMedCrossRef

18.

Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:448–57.CrossRef

19.

Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163–70.PubMed

20.

Cox DR. Regression models and life-tables (with discussion). J R Stat Soc. 1972;34:187–220.

21.

Venables WN and Ripley BD. Modern applied statistics with Splus. 3rd ed. New York: Springer; 1999.

22.

Mor V, Masterson-Allen S, Goldberg RJ, Cummings JF, Glicksman AS, Fretwell MD. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc. 1985;33:585–9.PubMed

23.

Asch SM, Sloss EM, Hogan C, Brook RH, Kravitz RL. Measuring underuse of necessary care among elderly Medicare beneficiaries using inpatient and outpatient claims. JAMA. 2000;284:2325–33.PubMedCrossRef

24.

Townsley C, Pond GR, Peloza B, Kok J, Naidoo K, Dale D, et al. Analysis of treatment practices for elderly cancer patients in Ontario, Canada. J Clin Oncol. 2005;23:3802–10.PubMedCrossRef

25.

Eaker S, Dickman PW, Bergkvist L, Holmberg L, Uppsala/Orebro Breast Cancer Group. Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med. 2006;3:e25.

26.

Hebert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol. 2004;22:3685–93.PubMedCrossRef

27.

Weiss SW, Goldblum JR. Enzinger and Weiss’s soft tissue tumors. 4th ed. St. Louis: Mosby; 2001.

28.

Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791–6.PubMedCrossRef

29.

Gutierrez JC, Perez EA, Franceschi D, Moffat FL Jr, Livingstone AS, Koniaris LG. Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res. 2007;141:105–14.PubMedCrossRef

30.

Heise HW, Myers MH, Russell WO, Suit HD, Enzinger FM, Edmonson JH, et al. Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer. 1986;57:172–7.PubMedCrossRef

31.

Singer S, Corson JM, Gonin R, Labow B, Eberlein TJ. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg. 1994;219:165–73.PubMedCrossRef

32.

Stefanovski PD, Bidoli E, De Paoli A, Buonadonna A, Boz G, Libra M, et al. Prognostic factors in soft tissue sarcomas: a study of 395 patients. Eur J Surg Oncol. 2002;28:153–64.PubMedCrossRef

33.

Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57:739–47.PubMed

34.

Marusyk A, DeGregori J. Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. Biochim Biophys Acta. 2008;1785:1–11.PubMed

Title: Complete Soft Tissue Sarcoma Resection is a Viable Treatment Option for Select Elderly Patients
Authors: G. Lahat, MD
A. R. Dhuka, BSc
S. Lahat, MD
A. J. Lazar, MD, PhD
V. O. Lewis, MD
P. P. Lin, MD
B. Feig, MD
J. N. Cormier, MD
K. K. Hunt, MD
P. W. T. Pisters, MD
R. E. Pollock, MD, PhD
D. Lev, MD
Publication date: 01-09-2009
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 9/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-009-0574-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Complete Soft Tissue Sarcoma Resection is a Viable Treatment Option for Select Elderly Patients

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2009

Reduced Axin Protein Expression Is Associated with a Poor Prognosis in Patients with Squamous Cell Carcinoma of Esophagus

Isolated Tumor Cells in Sentinel Lymph Node and Clinical Implications for Early Breast Cancer

Outcomes of Ablation Versus Resection for Colorectal Liver Metastases: Are We Comparing Apples with Oranges?

Synchronous Colorectal Liver Metastases: Is It Time to Reconsider Traditional Paradigms of Management?

Importance of Early Splenectomy in Patients with Hepatosplenic T-Cell Lymphoma and Severe Thrombocytopenia

Controversies in the Management of Hepatic Colorectal Metastases